Alumis draws Outperform at Oppenheimer
Oppenheimer downgrades Apple to Perform
Andres Oppenheimer, a columnist for the "Miami Herald," said the Trump administration is targeting illegal immigrants with ...
(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...
The card collecting industry has exploded in recent years to such an extent that industry leader Topps is now producing a Robert Oppenheimer card that's ...
British consumers’ appetite for home entertainment reached new heights in 2024, with the sector surpassing £5.1 billion ($6.4 ...
Amid the financial shock waves being sent by the release of DeepSeek's open source artificial intelligence R1 model, ...
Seeking Alpha on MSN3d
Top momentum subsectors according to Oppenheimer: capital markets, software, and moreWithin financials ( XLF ), Wald mentioned capital markets and the SPDR S&P Capital Markets ETF ( KCE) as a top idea, ...
Shares of Apple have surged roughly 40% over the past nine months, but one analyst issued a cautious warning that it’s time to tap the brakes ahead of the company’s earnings report set for Thursday.
In a report released yesterday, Kristen Owen from Oppenheimer maintained a Buy rating on Cf Industries Holdings (CF – Research Report), with a ...
Drug maker Alumis (ALMS) is climbing 7% after investment bank Oppenheimer started coverage of the name with an Outperform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback